FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
Roche Not Interested in Large Acquisitions, Says CEO -- Report
FDA Grants Genentech’s Avastin Priority Review for Certain Types of Cervical Cancer
Genentech’s Investigational Medicine Cobimetinib, Used in Combination with Zelboraf® (Vemurafenib), Helped People with Advanced Melanoma Live Significantly Longer Without Their Disease Worsening
Genentech to Buy Seragon Pharmaceuticals for up to $1.725 Billion
Genentech to Buy Seragon Pharma For up to $1.725 Billion
Roche to buy Seragon for up to $1.725 billion
These quality funds with smaller asset bases have portfolios built around solid companies.